Nitroglycerin 6.5 mg Oral Capsule
RxNorm 392173
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 392173 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: nitroglycerin 6.5 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Nitroglycerin 6.5 mg Oral Capsule
(Atom ID: 12326809)
SY
Synonym (SY):
Glyceryl trinitrate 6.5 mg oral capsule
(Atom ID: 10299299)
PSN
Prescribable Name (PSN):
Nitroglycerin 6.5 mg Oral Capsule
(Atom ID: 6364037)
PT
Designated preferred name (PT):
Nitroglycerin 6.5 mg oral capsule
(Atom ID: 10302369)
SY
Synonym (SY):
NTG 6.5 mg Oral Capsule
(Atom ID: 3851866)
FN
Full form of descriptor (FN):
Product containing precisely glyceryl trinitrate 6.5 mg/1 each conventional release oral capsule (clinical drug)
(Atom ID: 10313105)
SY
Synonym (SY):
TNG 6.5 mg Oral Capsule
(Atom ID: 3851865)
Patient Education
Nitroglycerin Sublingual
Nitroglycerin sublingual tablets are used to treat episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood vessels that supply blood to the heart). It is also used just before activities that may cause episodes of angina in order to prevent the angina from occurring. Nitroglycerin is in a class of medications called vasodilators. It works by relaxing the blood vessels so the heart does not need to work as hard and therefore does not need as much oxygen.
[Learn More]
* Please review the disclaimer below.